Acute lymphoblastic leukaemia.
Malard F, Mohty M.
Lancet. 2020 Apr 4;395(10230):1146-1162. doi: 10.1016/S0140-6736(19)33018-1.
Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial.
Jabbour E, Short NJ, Jain N, Huang X, Montalban-Bravo G, Banerjee P, Rezvani K, Jiang X, Kim KH, Kanagal-Shamanna R, Khoury JD, Patel K, Kadia TM, Daver N, Chien K, Alvarado Y, Garcia-Manero G, Issa GC, Haddad FG, Kwari M, Thankachan J, Delumpa R, Macaron W, Garris R, Konopleva M, Ravandi F, Kantarjian H.
Lancet Haematol. 2023 Jan;10(1):e24-e34. doi: 10.1016/S2352-3026(22)00319-2. Epub 2022 Nov 16.
The rewired immune microenvironment in leukemia.
Ciantra Z, Paraskevopoulou V, Aifantis I.
Nat Immunol. 2025 Mar;26(3):351-365. doi: 10.1038/s41590-025-02096-9. Epub 2025 Feb 28.
The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia.
Issa GC, Aldoss I, DiPersio J, Cuglievan B, Stone R, Arellano M, Thirman MJ, Patel MR, Dickens DS, Shenoy S, Shukla N, Kantarjian H, Armstrong SA, Perner F, Perry JA, Rosen G, Bagley RG, Meyers ML, Ordentlich P, Gu Y, Kumar V, Smith S, McGeehan GM, Stein EM.
Nature. 2023 Mar;615(7954):920-924. doi: 10.1038/s41586-023-05812-3. Epub 2023 Mar 15.
Refractory chronic lymphocytic leukemia--new therapeutic strategies.
Schnaiter A, Stilgenbauer S.
Oncotarget. 2010 Nov;1(7):472-482. doi: 10.18632/oncotarget.184.
Revumenib: First Approval.
Syed YY.
Drugs. 2025 Apr;85(4):577-583. doi: 10.1007/s40265-025-02161-5.
Treatment of relapsed or refractory chronic lymphocytic leukemia.
Veliz M, Pinilla-Ibarz J.
Cancer Control. 2012 Jan;19(1):37-53. doi: 10.1177/107327481201900105.
Efficacy of ruxolitinib in the treatment of relapsed/refractory large granular lymphocytic leukaemia.
Marchand T, Pastoret C, Damaj G, Lebouvier A, Herbaux C, Moignet A, Pavlosky M, Pavlosky A, Blouet A, Eloit M, Launay V, Lebreton P, Stamatoullas A, Nilsson C, Ochmann M, Prola J, Lamy T.
Br J Haematol. 2024 Sep;205(3):915-923. doi: 10.1111/bjh.19476. Epub 2024 Apr 19.
Treatment of fludarabine-refractory chronic lymphocytic leukemia.
Tsimberidou AM, Keating MJ.
Cancer. 2009 Jul 1;115(13):2824-36. doi: 10.1002/cncr.24329.
Hairy Cell Leukaemia.
Cross M, Dearden C.
Curr Oncol Rep. 2020 Apr 16;22(5):42. doi: 10.1007/s11912-020-00911-0.
